Year To Quarter End Consolidated Statement Of Comprehensive Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7325711

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-289,731,000 JPY
Comprehensive income
186,694,000 JPY
-289,731,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
186,694,000 JPY
-289,731,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.